Citizens And 2 Other Stocks Under $3 Insiders Are Buying
Citizens And 2 Other Stocks Under $3 Insiders Are Buying
Citizens 和其他兩隻低於3美元的股票內部人士正在買入
The Dow Jones index closed lower by around 10 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週一收盤下跌約10點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。
Citizens
市民
- The Trade: Citizens, Inc. (NYSE:CIA) Director Terry Sam Maness acquired a total of 1,000 shares an average price of $2.14. To acquire these shares, it cost around $2,137.
- What's Happening: On March 18, Citizens, named Jon Stenberg as President of Citizens.
- What Citizens Does: Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States.
- 貿易：公民公司（紐約證券交易所代碼：CIA）董事特里·薩姆·馬內斯 共收購了 1,000 股股份 平均價格爲2.14美元。收購這些股票的成本約爲2,137美元。
- 發生了什麼：3月18日，公民任命喬恩·斯坦伯格爲公民總統。
- 公民做什麼：Citizens Inc是一家保險控股公司，爲美國個人的人壽保險需求提供服務。
Tecogen
Tecogen
- The Trade: Tecogen Inc. (OTC:TGEN) Director John Hatsopoulos acquired a total of 1,000 shares at at an average price of $0.70. To acquire these shares, it cost around $700.
- What's Happening: On March 13, Tecogen reported revenues of $5.9 million and a net loss of $1.8 million for the quarter ended Dec. 31, 2023.
- What Tecogen Does: Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production.
- 交易：Tecogen Inc.（場外交易代碼：TGEN）董事約翰·哈索普洛斯 共收購了1,000股股票 平均價格爲0.70美元。收購這些股票的成本約爲700美元。
- 發生了什麼：3月13日，Tecogen公佈截至2023年12月31日的季度收入爲590萬美元，淨虧損180萬美元。
- Tecogen做什麼：Tecogen公司設計、製造、銷售和維護高效、超清潔的熱電聯產產品。它分爲三個業務領域，即產品、服務和能源生產。
Silo Pharma
思洛製藥
- The Trade: Silo Pharma, Inc. (NASDAQ:SILO) CEO and President Eric Weisblum acquired a total of 1,000 shares at an average price of $1.99. The insider spent around $1,988 to buy those shares.
- What's Happening: Silo Pharma approved extension of previously announced stock repurchase program authorizing purchase of up to $1 million common stock until April 30.
- What Silo Pharma Does: SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases.
- 交易：Silo Pharma, Inc.（納斯達克股票代碼：SILO）首席執行官兼總裁埃裏克·魏斯布魯姆 共收購了 1,000 股股份 平均價格爲1.99美元。知情人士花費了約1,988美元購買了這些股票。
- 發生了什麼：Silo Pharma批准將先前宣佈的股票回購計劃延長至4月30日，該計劃授權購買高達100萬美元的普通股。
- Silo Pharma做什麼：SILO Pharma Inc是一家處於發展階段的生物製藥公司，正在開發新療法，以解決服務不足的疾病，包括壓力誘發的精神疾病、慢性疼痛和中樞神經系統（CNS）疾病。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
資訊熱榜
更新時間